Comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 vs 15q11q13 Microduplication Syndrome C2675336
Clinical comparison between 3 Beta Hydroxysteroid Dehydrogenase Deficiency and 15q11q13 Microduplication Syndrome for differential diagnosis and treatment planning.
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
A rare genetic disorder affecting adrenal hormone production. It can cause ambiguous genitalia, salt-wasting crises, and hormonal imbalances. Treatment requires hormone replacement therapy and careful monitoring.
15q11q13 Microduplication Syndrome C2675336
A genetic disorder involving duplication of material from the chromosome 15 region linked to Prader-Willi and Angelman syndromes. Features may include developmental delays, learning difficulties, and sometimes autism spectrum traits. Supportive therapies help manage symptoms.
6 comparison axes
Onset
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
0-null
15q11q13 Microduplication Syndrome C2675336
0-3
Onset patterns differ
Severity
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
severe
15q11q13 Microduplication Syndrome C2675336
moderate
Different severity levels
Chronic
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
Chronic
15q11q13 Microduplication Syndrome C2675336
Chronic
Differing course
Communicable
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
No
15q11q13 Microduplication Syndrome C2675336
No
Different transmission
Body System
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
15q11q13 Microduplication Syndrome C2675336
congenital
Same/different system
Category
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
15q11q13 Microduplication Syndrome C2675336
genetic
Different category
Bottom line
3-beta-hydroxysteroid-dehydrogenase-deficiency-C0342471 and 15q11q13-microduplication-syndrome-C2675336 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 15q11q13 Microduplication Syndrome C2675336 | Discriminating power |
|---|---|---|---|
| Salt-wasting crisis | May cause vomiting, dehydration, low blood pressure, or electrolyte disturbance in infancy. | Not a characteristic feature based on the supplied description. | High |
| Genital development | Ambiguous genitalia may occur because of disordered sex-steroid production. | Genital ambiguity is not described as a typical feature. | High |
| Neurodevelopment | Developmental delay is not the defining feature in the supplied source. | Developmental delay, learning difficulty, and sometimes autism-spectrum traits may occur. | Moderate |
When to favor each condition
Choose 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 when
Infant with suspected adrenal crisis
Salt wasting and hormonal imbalance point toward an adrenal steroid-synthesis disorder.
High
Ambiguous genitalia with endocrine concern
Disordered adrenal and gonadal steroid production can affect genital development.
Moderate
Abnormal steroid profile needing specialist review
A steroid-pathway disorder is more plausible than a chromosomal duplication, but confirmation is required.
Moderate
Choose 15q11q13 Microduplication Syndrome C2675336 when
Developmental delay or learning difficulty
These are central features described for the chromosomal duplication.
Moderate
Autism-spectrum traits with congenital genetic suspicion
Such traits may occur, although they are not specific to this syndrome.
Low
Chromosomal microarray suggests 15q11q13 duplication
Genetic testing, interpreted by a clinician, is the appropriate basis for this diagnosis.
High
How key tests differ
| Test | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 15q11q13 Microduplication Syndrome C2675336 | Interpretation |
|---|---|---|---|
| Serum electrolytes | May show salt-wasting-related abnormalities during illness; exact cutoffs are not supplied. | No characteristic electrolyte abnormality is established here. | Abnormal electrolytes suggest adrenal crisis but do not alone diagnose either condition. |
| Steroid hormone profile | May show disordered adrenal and gonadal steroid production; pattern requires specialist interpretation. | No characteristic steroid abnormality is described. | An abnormal profile is a finding, not a completed diagnosis. |
| Chromosomal microarray | Not expected to identify this enzyme deficiency. | May detect duplication involving 15q11q13 when clinically indicated. | Genetic confirmation and clinical correlation are required. |
Prognosis comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
- Outcome
- Potentially severe but outcomes vary; reliable mortality or prognosis figures are not supplied.
- Factors
- Crisis recognition, hormone replacement, and specialist monitoring are important.
15q11q13 Microduplication Syndrome C2675336
- Outcome
- Often moderate developmental impact, with wide individual variation.
- Factors
- Degree of developmental delay, learning needs, and access to supportive therapies influence outcome.
Time frame: Both are chronic; meaningful prognosis requires individualized clinical assessment.
Genetic confirmation, associated complications, and response to appropriate support affect course.
Complications comparison
| Complication | Presentation |
|---|---|
| Adrenal crisis | A potentially severe complication related to impaired adrenal hormone production. Not described as characteristic. Urgent clinical assessment is needed for vomiting, dehydration, or collapse. |
| Learning and developmental difficulty | Not established as a defining complication from the supplied data. May be a major ongoing feature. Educational and developmental support should be individualized. |
| Hormonal imbalance | Central and may require long-term hormone replacement and monitoring. Not described as the primary problem. Treatment details and doses must be determined by a specialist. |
Patient education highlights
- HighEmergency warning signs
Seek urgent care for vomiting, poor feeding, dehydration, lethargy, or collapse, especially in an infant with the adrenal disorder.
- HighDifferent conditions
These disorders have different causes and testing pathways; one abnormal result does not establish either diagnosis.
- MediumLong-term support
The adrenal condition needs endocrine follow-up, while the duplication syndrome often needs developmental, educational, and behavioral support.